Publications by authors named "Alan A Martin"

Claim this Profile
E
Economic Analysis of New Single-Inhaler Triple Therapies in Patients with COPD in the UK.
Rui Cai, Alan A Martin, Yuchen Ge, Nancy A Risebrough, Katrin Haeussler

Int J Chron Obstruct Pulmon Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK.
Robyn Kendall, Alan A Martin, Dhvani Shah, Soham Shukla, Chris Compton

Int J Chron Obstruct Pulmon Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.
Carol Mansfield, Mirko V Sikirica, Amy Pugh, Christine M Poulos, Victoria Unmuessig, Alan A Martin

Diabetes Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes.
Mirko V Sikirica, Alan A Martin, Robert Wood, Andrea Leith, James Piercy

Diabetes Metab Syndr Obes· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility of albiglutide versus insulin lispro, insulin glargine, and sitagliptin for the treatment of type 2 diabetes in the US.
David Bruhn, Alan A Martin, Ruben Tavares, Barnaby Hunt, Richard F Pollock

J Med Econ· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-reported Barriers to Adherence and Persistence to Treatment With Injectable Medications for Type 2 Diabetes.
C Victor Spain, Jonathon J Wright, Rebecca M Hahn, Ashley Wivel, Alan A Martin

Clin Ther· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An indirect comparison of HbA1c treatment effect with albiglutide and exenatide 2.0 mg QW using the Bucher method.
Alan A Martin, Daniel Parks

Diabetes Metab Syndr Obes· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic burden of progressive chronic kidney disease among patients with type 2 diabetes.
Suma Vupputuri, Teresa M Kimes, Michael O Calloway, Jennifer B Christian, David Bruhn, Alan A Martin

J Diabetes Complications· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis